CeriBell

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Stuttgart,,Germany,-,07-01-2023:,Person,Holding,Cellphone,With,Logo,Of

News

Intraday Update

Markets

Movers

Trading Ideas

ABSI

AMRN

CBLL

CERT

FAST

NMAX

RXRX

SDGR

ZLAB

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday

Konskie,,Poland,-,February,22,,2025:,Lattice,Semiconductor,Company,Logo

Initiation

Pre-Market Outlook

Analyst Ratings

LSCC

TSX:TRP

This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

movers image

$BTC

AEMD

ALCE

BDMD

CETY

CGBS

CMCT

DMRC

MSTR

NRXP

ORIS

SIDU

VEEE

VRME

VSME

Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today&#39;s pre-market trading.

Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

CeriBell Inc

Press Releases

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Health Care

Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference

Earnings

Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results

Legal

FDA Clears Ceribell's Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

General

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

Management

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

Ceribell Reports First Quarter 2025 Financial Results

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

AngioDynamics

Artivion

AtriCure

Axogen

Beta Bionics

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

ClearPoint Neuro

Conmed

Delcath Systems

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

Kestra Medical Technologies, Ltd. - Common Stock

Kestra Medical Techs

NeuroPace

Orthofix Medical

Outset Medical

Omnicell

Pulse Biosciences

Senseonics Holdings

SI-BONE

Semler Scientific

Surmodics

SS Innovations International Inc. - Common Stock

SS Innovations

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

Varex Imaging

Ladenburg Thalmann

Canaccord Genuity

TD Cowen

JP Morgan

B of A Securities

Comments

CeriBell

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell